Scott Hitchcock, DO
Neurology · Huntsville, ALNPI 1255327557
Payments from drug & device makers
Across 2,380 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$4K
- AbbVie$4K
- Novartis$2K
- Biogen$2K
- CSL Behring$2K
- Pfizer$2K
- plus $24K from 54 others
What the payments were for
- Speaking & faculty fees$1950%
- Food & beverage$40,62899%
- Education$1390%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GOCOVRI$330
How this compares
$40,962 in reported general payments places this provider in the 75th percentile of 255 neurology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammakedImmune Globul G/Gly/Iga Avg 46 | 48 | $997,006 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 41 | $895,539 |
| IngrezzaValbenazine Tosylate | 38 | $323,712 |
| Kesimpta PenOfatumumab | 31 | $304,197 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 25 | $216,935 |
| UbrelvyUbrogepant | 87 | $100,647 |
| Nurtec OdtRimegepant Sulfate | 64 | $99,596 |
| NuedextaDextromethorphan Hbr/Quinidine | 43 | $68,563 |
| GlatopaGlatiramer Acetate | 12 | $56,621 |
| Aimovig AutoinjectorErenumab-Aooe | 70 | $54,793 |
| BriviactBrivaracetam | 31 | $54,515 |
| VimpatLacosamide | 32 | $52,195 |
| QuliptaAtogepant | 38 | $44,731 |
| FingolimodFingolimod Hcl | 17 | $28,388 |
| Sumatriptan Succinate | 202 | $26,287 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringPrivigen | $2,139 | $895,53941 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $1,144 | $323,71238 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $137 | $216,93525 claims |
| AbbVieUbrelvy, Qulipta | $3,902 | $145,378125 claims |
| UCB, Inc.Briviact, Vimpat | $3,907 | $106,71163 claims |
| PfizerNurtec Odt | $1,717 | $99,59664 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $616 | $68,56343 claims |
| MerckBelsomra | $162 | $21,99751 claims |
| Supernus Pharmaceuticals, Inc.Trokendi Xr | $641 | $17,51114 claims |
| Amneal Pharmaceuticals LLCRytary | $250 | $7,99415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 255 neurology providers in Alabama.
Other neurology in Huntsville
- Belinda Savage-EdwardsHuntsville$2.8M
- Harry McDarisHuntsville$307K
- Anjaneyulu AlapatiHuntsville$133K
- Bhageeradh MulpurHuntsville$74K
- David GreerHuntsville$67K
- David WhiteHuntsville$40K
- Emily RiserBirmingham$7.1M
- Christopher LagankeCullman$5.9M
- Louis NaborsBirmingham$3.2M
- Khurram BashirBirmingham$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.